Product Information

RASAGILINE MESYLATE 0.5 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.4545 per EA under NDC 64980071130. Its NADAC has been published 36 times since Dec 17, 2025.

FDA first approved this application on Apr 9, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RASAGILINE MESYLATE 0.5 MG TAB

Rasagiline mesylate
$0.4545per EA

Strength

.5 mg/1

NDC

64980071130

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

RASAGILINE MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA218163

FDA Approved

4/9/2024

TE Code

AB

On Market Since

7/21/2025

Pharmacological Classes

Monoamine Oxidase Inhibitor
Monoamine Oxidase Inhibitors

Price Statistics

The NADAC for RASAGILINE MESYLATE 0.5 MG TAB has been published 36 times since Dec 17, 2025, and over the history we have for it it has declined 64.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4545 per EA
All-time high$1.2855 (Jan 14, 2026)
All-time low$0.4545 (Aug 19, 2026)
52-week high$1.2855
52-week low$0.4545
Median price$0.9710
Average price$0.9486
Largest weekly change-21.6% (Aug 19, 2026)
Weeks tracked36
Tracking sinceDec 17, 2025

Price History

1W

-21.6%

1M

-31.8%

3M

-41.9%

6M

-61.9%

1Y

N/A

3Y

N/A

5Y

N/A

All

-64.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RASAGILINE MESYLATE 0.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for RASAGILINE MESYLATE 0.5 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.4545 per EA (NDC 64980071130), effective Aug 19, 2026.

How has the price of RASAGILINE MESYLATE 0.5 MG TAB changed over time?

Over the history we have for it, the NADAC for RASAGILINE MESYLATE 0.5 MG TAB has declined 64.6%. It has been tracked across 36 weekly CMS publications since Dec 17, 2025.

What are the highest and lowest recorded NADAC prices for RASAGILINE MESYLATE 0.5 MG TAB?

Since Dec 17, 2025, the NADAC for RASAGILINE MESYLATE 0.5 MG TAB has ranged from a low of $0.4545 (Aug 19, 2026) to a high of $1.2855 (Jan 14, 2026), with a median of $0.9710 per EA.

Are there cheaper alternatives to RASAGILINE MESYLATE 0.5 MG TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RASAGILINE MESYLATE 0.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures RASAGILINE MESYLATE 0.5 MG TAB?

RASAGILINE MESYLATE 0.5 MG TAB (NDC 64980071130) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.